Related Experiment Video
Updated: Jun 13, 2025
08:55
The Colon-26 Carcinoma Tumor-bearing Mouse as a Model for the Study of Cancer Cachexia
Published on: November 30, 2016
16.2K
Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging
Fabio Penna1, Giacomo Rubini1, Paola Costelli1
1Department of Clinical and Biological Sciences, University of Turin, Italy.
Molecular Aspects of Medicine
|September 11, 2024
Summary
Cancer cachexia, a common comorbidity, involves complex immune system changes. Immunomodulating strategies may offer a novel approach to combatting cancer cachexia and age-related muscle wasting.
Area of Science:
- Oncology
- Immunology
- Geriatrics
Background:
- Cancer cachexia is a frequent comorbidity in cancer patients, stemming from tumor growth and inflammation.
- Anti-cancer therapies can worsen cachexia, leading to treatment complications.
- The exact pathogenesis of cancer cachexia remains unclear, involving nutritional, metabolic, hormonal, and immunological factors.
Purpose of the Study:
- To review immune system dysregulations in cancer cachexia.
- To explore the potential of immunomodulating strategies in counteracting cachexia.
- To discuss the overlap between cancer cachexia and aging-associated sarcopenia.
Main Methods:
- Literature review focusing on immune system alterations in cancer cachexia.
- Analysis of the role of immune cells and peripheral tissue homeostasis.
- Discussion of immunomodulation as a therapeutic strategy.
Main Results:
- Immune system dysregulation is a key feature of cancer cachexia.
- Tumor-induced immune modulation can influence cachexia development.
- Shared mechanisms exist between cancer cachexia and aging-related sarcopenia.
Conclusions:
- Immunomodulating strategies, designed for anti-cancer immunity, may be repurposed for cachexia.
- Understanding immune interactions is crucial for cachexia management.
- Immunomodulation holds potential for treating both cancer cachexia and sarcopenia.
Related Concept Videos
01:27Tumor Immunotherapy
491
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
491
01:30Cancer Vaccines
345
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
345
01:19Psychoneuroimmunology: Diabetes and Cancer
26
Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
26
02:43Mouse Models of Cancer Study
5.5K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
5.5K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K